News
Philips has announced the expansion of its collaboration with Medtronic, focusing on advancing patient monitoring ...
Escala Medical has pulled in €4.5m ($5.3m) to drive market expansion of its Mendit device for women with pelvic organ ...
A court has approved the $305m sale of 23andMe’s assets to a nonprofit led by former 23andMe CEO Anne Wojcicki.
Nanostics has secured funding from Genome Canada and Genome Alberta to expedite the ClarityDX Prostate test integration into ...
Enterra Medical has commenced the randomised, multi-centre NAVIGATE study, designed to assess Gastric Electrical Stimulation ...
Glaukos has secured EU Medical Device Regulation (EU-MDR) certification for its iStent infinite, along with other MIGS ...
Drug discovery has traditionally been slow, expensive and prone to failure, but AI and machine learning are set to change all ...
The FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests.
Medical Research Council (MRC) has launched a new £50m ($68.6m) centre spread across collaborator sites in the UK to develop ...
Vivasure Medical has submitted an application seeking premarket approval from the FDA for its PerQseal Elite vascular closure ...
ITM and Swiss-based Debiopharm have announced the imaging of the first subject in a new study arm (Part D) of the Phase I/II ...
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Stryker’s Incompass Total Ankle System.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results